Denis Horgan
Overview
Explore the profile of Denis Horgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horgan D, Tanner M, Aggarwal C, Thomas D, Grover S, Basel-Salmon L, et al.
JCO Glob Oncol
. 2025 Jan;
11():e2400416.
PMID: 39847746
Despite the acknowledged merits of precision oncology (PO) and its increasing global implementation, its full potential for advancing care and prevention remains unrealized. The benefits are currently accessible to only...
2.
Horgan D, Hofman P, Giacomini P, Dube F, Singh J, Schneider D, et al.
Diagnosis (Berl)
. 2024 Dec;
PMID: 39686656
Personalized medicine, aiming to tailor treatments based on individual patient characteristics, holds immense potential in oncology. However, its widespread adoption in Europe faces numerous challenges, as illustrated by the case...
3.
Horgan D, Van Den Bulcke M, Malats N, De Maria R, Dube F, Singh J, et al.
Healthcare (Basel)
. 2024 Dec;
12(23).
PMID: 39684960
Background: A comparison of the operations of Clinical Cancer Centers and Comprehensive Cancer Centers across Europe provides novel data on the interrelation between different factors in care delivery. Method: The...
4.
Pesapane F, Hauglid M, Fumagalli M, Petersson L, Parkar A, Cassano E, et al.
Eur J Radiol
. 2024 Nov;
182:111852.
PMID: 39612599
This manuscript delineates the pathway from in-house research on Artificial Intelligence (AI) to the development of a medical device, addressing critical phases including conceptualization, development, validation, and regulatory compliance. Key...
5.
Lawlor A, Beyer K, Russell B, Steinbeisser C, Bjartell A, De Meulder B, et al.
Nat Rev Urol
. 2024 Sep;
22(2):116-124.
PMID: 39251785
Prostate Cancer Diagnosis and Treatment Enhancement through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer. PIONEER brings together...
6.
Horgan D, Hofman P, Buttner R, Riess O, Lugowska I, Dube F, et al.
Diagnosis (Berl)
. 2024 Aug;
12(1):94-107.
PMID: 39088796
Objectives: This paper aims to identify and address gaps in cancer treatment and diagnosis within European health services, focusing specifically on discrepancies between clinical guidelines and policy guidelines. It seeks...
7.
Horgan D, Pesapane F, Van der Buckle M, De Maria R, Dube F, Singh J, et al.
Crit Rev Oncol Hematol
. 2024 Jul;
201:104433.
PMID: 38955310
If Europe's health systems make a conscious decision to increase their utilization of technology and techniques that can enhance prevention and expedite early-stage diagnosis, they can effectively address the growing...
8.
Ilie M, Heeke S, Horgan D, Hofman P
J Clin Oncol
. 2024 Jun;
42(27):3183-3186.
PMID: 38935877
Navigating change in tumor naming. Balance organ-based and molecular classifications for optimal treatment.
9.
McCrary J, Van Valckenborgh E, Poirel H, de Putter R, van Rooij J, Horgan D, et al.
Eur J Public Health
. 2024 Jun;
34(4):666-675.
PMID: 38905592
Background: Somatic and germline genetic alterations are significant drivers of cancer. Increasing integration of new technologies which profile these alterations requires timely, equitable and high-quality genetic counselling to facilitate accurate...
10.
Horgan D, Van Den Bulcke M, Malapelle U, Normanno N, Capoluongo E, Prelaj A, et al.
Curr Oncol
. 2024 Apr;
31(4):1839-1864.
PMID: 38668042
Understanding the diversity in cancer research priorities and the correlations among different treatment modalities is essential to address the evolving landscape of oncology. This study, conducted in collaboration with the...